Remote sensor may let heart failure patients Self-Tune diuretics

NCT ID NCT07743125

Completed Disease control Sponsor: Medical College of Wisconsin Source: ClinicalTrials.gov ↗

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This study tests whether adults with heart failure who have an implanted pulmonary artery pressure sensor can safely adjust their own diuretic (water pill) doses. Participants follow a simple guide to change their medication based on daily pressure readings sent to their phone or patient portal. The study tracks safety events like hospitalizations and kidney issues, as well as how well the approach controls heart failure symptoms over 90 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Shared-management diuretic titration guided by remote pulmonary artery pressure monitoring
What this could lead to: If successful, this could empower heart failure patients to manage their own fluid levels at home, potentially reducing hospitalizations and improving quality of life.
What could go wrong: This is a small, early feasibility study, so results may not apply broadly. There are risks of over- or under-diuresis, leading to kidney injury or electrolyte imbalances.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE

Contacts and locations

Locations

Froedtert Menomonee Falls Hospital

Menomonee Falls, Wisconsin, 53051, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.